|
|
|
|
|
|
This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
Clearing Senescent CellsWhat a Japanese PGAM1-Chk1 Discovery Reveals-and Why Accelerated Aging Is ModifiableRichard Z. Cheng, MD, PhD
IntroductionAging is often discussed as if it were a single, inevitable biological process. Modern geroscience, however, increasingly recognizes that aging is heterogeneous-comprising both physiological aging, which is time-dependent and unavoidable, and accelerated aging, which reflects chronic biological stress and is, at least in part, modifiable. A recent study from a Japanese research group, published in Signal Transduction and Targeted Therapy, provides a rare level of molecular clarity on this distinction. The work demonstrates that senescent ("aging") cells do not merely persist passively, but actively survive by exploiting a stressed metabolic and DNA-repair environment. This discovery has important implications for anti-aging medicine-and for how senescence should be addressed clinically. 1. The Japanese discovery: a lactate-driven survival circuit in senescent cellsThe Japanese investigators identified a previously underappreciated survival dependency in senescent cells. Their key findings can be summarized as follows:
In plain terms, the study identifies a terrain-dependent "life-support circuit": glycolysis → lactate signaling → checkpoint-repair tolerance → senescent persistence This is a significant advance. It shifts senescence from being viewed as a passive end-stage phenomenon to an active, stress-supported survival state. 2. Why this matters for anti-aging medicineThe accumulation of senescent cells with age is strongly associated with tissue dysfunction, chronic inflammation (via SASP), impaired regeneration, and increased disease risk. Accordingly, senolysis-the selective removal of senescent cells-has become a major focus in longevity research. What distinguishes this Japanese study is that it demonstrates how senescent cells survive. Rather than relying on nonspecific cytotoxicity, the approach exploits a selective vulnerability created by metabolic distortion and DNA-damage tolerance. This provides compelling proof-of-concept that senescent cells can be selectively destroyed. At the same time, the study raises a deeper and more important question: Why do senescent cells increasingly depend on glycolysis, lactate, and Chk1-mediated damage tolerance in the first place? The answer points upstream-to the biological terrain. 3. Senescence, natural aging, and accelerated agingCellular senescence itself is not inherently pathological. Transient senescence plays essential roles in development, tumor suppression, wound healing, and tissue remodeling. This physiological senescence is normally limited in time and efficiently cleared. By contrast, accelerated aging is characterized by the excessive accumulation and persistence of senescent cells. In Integrative Orthomolecular Medicine (IOM), this accelerated senescence is viewed as a downstream manifestation of upstream root drivers-chronic biological stressors that enforce sustained DNA-damage responses, metabolic distortion, and inflammatory feedback loops. The Japanese PGAM1-Chk1 study addresses precisely this pathological persistence. It does not challenge natural aging; it explains why senescent cells fail to resolve under chronic stress conditions. 4. Metabolic terrain: low-carbohydrate and ketogenic strategiesA central implication of the Japanese discovery is that senescent cells are metabolically supported. Their persistence depends on glycolysis and lactate signaling. Independent work in Nature Metabolism has shown that senescent cells can adopt PDK4-dependent aerobic glycolysis with increased lactate production, even while remaining growth-arrested. This mirrors the metabolic dependency exploited by the PGAM1-Chk1 interaction. From this perspective, low-carbohydrate and ketogenic dietary strategies occupy a legitimate place in anti-aging medicine-not as senolytic therapies, but as terrain-modifying interventions:
Such approaches are best understood as senomorphic-altering the environment that supports senescent survival-rather than as agents that directly kill senescent cells. 5. Oxidative stress, inflammation, and Chk1 dependenceChk1 is not an "aging protein"; it is a stress-response kinase. Persistent reliance on Chk1 reflects ongoing DNA damage and replication stress, often driven by oxidative and inflammatory burden. A broad literature demonstrates that:
The Japanese study's emphasis on Chk1-mediated damage tolerance therefore implicitly implicates redox imbalance and chronic inflammation as upstream drivers of senescent persistence. Orthomolecular medicine addresses this domain directly by restoring antioxidant capacity, redox balance (氧化还原系统), mitochondrial function, and micronutrient sufficiency-not by inhibiting Chk1, but by reducing the biological need for checkpoint-dependent survival. 6. Endocrine context, the ICV axis, and BHRTAlthough the Japanese study does not explicitly examine hormonal regulation, its findings intersect with endocrine biology in important ways. Within IOM, the Insulin-Cortisol-Vitamin C (ICV) axis integrates metabolic control, stress physiology, and redox regulation:
These factors directly influence the same stressors-glycolytic reprogramming and checkpoint dependence-identified in the Japanese work. Similarly, bioidentical hormone replacement therapy (BHRT) influences mitochondrial function, oxidative stress signaling, and DNA-damage response pathways. Emerging human data suggest that hormonal milieu can alter circulating senescence-associated biomarkers, indicating that endocrine context modulates senescence biology, even if precise molecular links remain under investigation. Importantly, neither the ICV axis nor BHRT should be viewed as direct anti-senescence treatments. Rather, they may reduce the upstream drivers that force cells into stress-stabilized senescence. 7. The Two-Tier Anti-Aging SystemThe Japanese PGAM1-Chk1 discovery fits naturally within a Two-Tier model of anti-aging medicine:
The Japanese study represents a powerful Tier-2-relevant tool, but its own mechanistic logic reinforces why Tier-1 terrain correction is indispensable for durable benefit. ConclusionThe Japanese discovery that senescent cells depend on glycolysis-derived lactate signaling and Chk1-mediated DNA-damage tolerance provides a strong mechanistic foundation for a terrain-based understanding of accelerated aging. It confirms that senescent cells are active survivors, maintained by distorted metabolism and stress signaling. Removing such cells is important. Preventing their accelerated formation and persistence is more important. This balance-between selective removal and upstream prevention-is the essence of Integrative Orthomolecular Medicine and of rational anti-aging medicine in the 21st century. DisclaimerThis article is for scientific discussion and information exchange only and does not constitute medical advice. Any intervention discussed should be undertaken under the supervision of a trained and experienced healthcare professional. Key References and Further ReadingPrimary Mechanistic Anchor (Japanese Discovery)1. Mikawa T, et al.
Metabolic Reprogramming, Glycolysis, and Lactate in Senescence2. Dou X, et al.
PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy.
3. Sabbatinelli J, et al.
4. Liu B, et al.
Oxidative Stress, DNA Damage Response, and Senescence5. Stojanovic B, et al.
6. Wang L, et al.
Physiological vs. Pathological Senescence7. Huang W, et al.
Metabolic Interventions and Aging Context8. Wei S-J, et al.
Inflammation, SASP, and Senescent Persistence10. Coppé J-P, et al.
Lifestyle Modulation and Senescent Burden11. Englund DA, et al.
Systems-Level Aging Framework12. Cheng RZ.
A Two-Tier Systems Medicine Model for Human Longevity: Restorative and Regenerative Pathways to the 120-Year Lifespan Potential.
Orthomolecular MedicineOrthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org Find a DoctorTo locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource. Editorial Review Board:
Jennifer L. Aliano, M.S., L.Ac., C.C.N. (USA)
Comments and media contact: editor@orthomolecular.org OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication. To Subscribe at no charge: https://www.orthomolecular.org/subscribe.html To Unsubscribe from this list: https://www.orthomolecular.org/unsubscribe.html |
This website is managed by Riordan Clinic
A Non-profit 501(c)(3) Medical, Research and Educational Organization
3100 North Hillside Avenue, Wichita, KS 67219 USA
Phone: 316-682-3100; Fax: 316-682-5054
© (Riordan Clinic) 2004 - 2024c
Information on Orthomolecular.org is provided for educational purposes only. It is not intended as medical advice.
Consult your orthomolecular health care professional for individual guidance on specific health problems.
